Reduced consumption of tobacco and alcoholWeight bearing and resistance exercises
Adequate vitamin D and vitamin k supplementation in post menopausal women. Balanced diet with optimum levels of calcium.
Bisphosphonates are useful in decreasing the risk of future fractures in those who have already sustained a fracture due to osteoporosis. This benefit is present when taken for three to four years under strict medical supervision. Alendronate may decrease fractures of the spine
Teriparatide ( a recombinant parathyroid hormone ) has been shown to be effective in treatment of women with postmenopausal osteoporosis.Some evidence also indicates strontium ranelate is effective in decreasing the risk of vertebral and nonvertebral fractures in postmenopausal women with osteoporosis. Hormone replacement therapy, while effective for osteoporosis, is only recommended in women who also have menopausal symptoms.Raloxifene, while effective in decreasing vertebral fractures, does not affect the risk of nonvertebral fracture. Denosumab is also effective for preventing osteoporotic fractures. In hypogonadal men, testosterone has been shown to improve bone quantity and quality, but, as of 2008, no studies evaluated its effect on fracture risk or in men with a normal testosterone levels.Calcitonin while once recommended is no longer due to the associated risk of cancer with its use and questionable effect on fracture risk.
Certain drugs like alendronate, etidronate, risedronate, raloxifene and strontium ranelate can be helpful for the primary prevention of osteoporotic fragility fractures in postmenopausal women